期刊文献+

兔组织笼无菌感染模型的制备

The preparation of aseptic rabbit tissue cage infection model
下载PDF
导出
摘要 目的制备兔组织笼无菌感染模型,为药物药动学-药效学结合模型(pharmacokinetic-pharmacodynamic modeling,PK-PD)研究提供在体动物实验载体。方法选取健康家兔28只,耳缘静脉注射盐酸赛拉嗪注射液0.15ml/kg麻醉,每只分别背部备皮、切开皮肤,然后在皮下植入长约5cm的无菌中空胸腔引流管1个,继而在无菌操作下手术缝合。术后应用青霉素肌肉注射3d以预防感染。结果 5只家兔先后因不同原因死亡,23只家兔均获得清亮的无菌组织液,成功建立兔组织模型,成功率为82.14%。结论通过严格控制无菌操作,选择合适的麻醉剂,手术刀口选择在兔背部,术后及时预防感染,可以成功制备兔组织笼无菌感染模型,并获得清亮的无菌组织液。 Objective To prepare a rabbit tissue cage model so as to provide drug animal carrier in vivo for drug PK-PD modeling study.Methods 28 healthy rabbits were selected and injected with the anesthesia xylazine iv respectively.The back hair was cut in each rabbit,and then the skin was cut open.A5 cm of sterile hollow chest tube drainage was implanted subcutaneously.In the end the wound was sewed up with aseptic technique.After operation penicillin im was injected for 3 days to prevent infection.Results Among the 28 rabbits,5 rabbits were dead due to different causes.Clear and sterile tissue fluid were gotten from other 23 rabbits.A rabbit tissue model was established successfully,and the success rate was 82.14%.Conclusion By stricted controlling aseptic operation,selecting the appropriate anesthesia and surgical incision in the back of the rabbit,timely postoperative anti-infection,a rabbit tissue cage model can be successfully established,so does clear tissue fluid.
出处 《济宁医学院学报》 2015年第1期23-25,共3页 Journal of Jining Medical University
基金 2010年山东省自然科学基金项目(编号:ZR2010BL031) 2013年济宁医学院基金项目(编号:JY2013KJ011)
关键词 兔组织笼模型 PK-PD 无菌操作 组织液 A rabbit tissue cage model PK-PD modeling Aseptic technique Tissue fluid
  • 相关文献

参考文献6

二级参考文献21

  • 1姬汴生,张银娣.美多洛尔药动学药效学结合模型的研究[J].河南医科大学学报,1995,30(1):34-36. 被引量:3
  • 2童卫杭,柴栋,崔俊昌,陈锟,王睿.兔感染性模型组织液中左氧氟沙星浓度HPLC测定[J].中国抗生素杂志,2005,30(12):759-761. 被引量:6
  • 3李朝霞,刘又宁,王睿,崔俊昌,程仕虎,童卫杭.氟喹诺酮类药物对金黄色葡萄球菌及其耐药突变体的耐药性研究[J].中国临床药理学与治疗学,2006,11(6):696-701. 被引量:17
  • 4Fernandez J,Barrett JF,Licata L,et al.Comparison of efficacies of oral levofloxacin and coiprofloxacin in a rabbit model of a staphylococcal abscess[J].Antimicrob Agents Chemother,1999,43(3):667-671.
  • 5Peng WM.Components and physiology of tissue fluid[J].Bull Biol,1999,34(2):14-16.
  • 6Sheiner LB,Stanski DR,Vozeh S,etal.Simultaneous modeling of pharmacokineiics and pharmacodynamics:Application to dtubocurarine[J].Clin Pharmacol Ther,1979;25(3):358.
  • 7Meibohm B,Derendorfh Basic concepts of pharmacokinetic/pharm-acodynamic modeling[J].Int J Clin pharmacol Ther,1997,35(10):401.
  • 8Shi J,Benowitz NL,Denaro CP,et al.pharmacokinetic-pharmacodynamic modeling of Ajmaline:the Efects on Arrhythmia[J].Clin Pharmacol Ther,1993,53(1):6.
  • 9Stein GE.Pharmacokinetics and pharmacodynamics of newer fluoroquinolones[J].Clin Infect Dis,1996;23(Supple 1):S19-S24.
  • 10Aminimanizani A,Beringer P,Jelliffe R.Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials[J].Clin Pharmacokinet,2001;40:169-187.

共引文献280

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部